Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors by Jeffrey R. Strawn, Jeffrey R. Strawn, Jeffrey R. Strawn, Ethan A. Poweleit, Ethan A. Poweleit, Ethan A. Poweleit, Ethan A. Poweleit, Chakradhara Rao S. Uppugunduri, Laura B. Ramsey, Laura B. Ramsey

Connect to this object online.

SLCO1B1 *15 allele is associated with methotrexate‐induced nausea in pediatric patients with inflammatory bowel disease by Rishi S. Mehta, Zachary L. Taylor, Lisa J. Martin, Michael J. Rosen, Laura B. Ramsey

Connect to this object online.

Characterizing Pharmacogenetic Testing Among Children's Hospitals by Jacob T. Brown, Laura B. Ramsey, Sara L. Van Driest, Ida Aka, Susan I. Colace

Connect to this object online.

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders by Stacey L. Aldrich, Stacey L. Aldrich, Ethan A. Poweleit, Cynthia A. Prows, Cynthia A. Prows, Lisa J. Martin, Lisa J. Martin, Jeffrey R. Strawn, Jeffrey R. Strawn, Laura B. Ramsey, Laura B. Ramsey

Connect to this object online.

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model by Zachary L. Taylor, Lauren E. Thompson, Heather Bear, Tomoyuki Mizuno, Alexander A. Vinks, Laura B. Ramsey

Connect to this object online.

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications by Ethan A. Poweleit, Ethan A. Poweleit, Ethan A. Poweleit, Ethan A. Poweleit, Margaret A. Cinibulk, Sarah A. Novotny, Melissa Wagner-Schuman, Laura B. Ramsey, Laura B. Ramsey, Jeffrey R. Strawn, Jeffrey R. Strawn, Jeffrey R. Strawn

Connect to this object online.

Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series by Andrea Edwards, Ashley Teusink‐Cross, Lisa J. Martin, Cynthia A. Prows, Parinda A. Mehta, Laura B. Ramsey

Connect to this object online.

Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients by Alaa Alghamdi, Sarah Seay, David K. Hooper, Charles D. Varnell Jr, Leanna Darland, Tomoyuki Mizuno, Danielle Lazear, Laura B. Ramsey

Connect to this object online.

Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition by Nina R. Sperber, Megan C. Roberts, Sarah Gonzales, Lisa M. Bendz, Deborah Cragun, Susanne B. Haga, R. Ryanne Wu, Chioma Omeogu, Brystana Kaufman, Natasha J. Petry, Laura B. Ramsey, Ryley Uber

Connect to this object online.

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org by Zachary L. Taylor, Tamara P. Miller, Ethan A. Poweleit, Nicholas P. DeGroote, Lauren Pommert, Oluwafunbi Awoniyi, Sarah G. Board, Ngozi Ugboh, Vivek Joshi, Nick Ambrosino, Ashley Chavana, Melanie B. Bernhardt, Eric S. Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey

Connect to this object online.

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy by Sony Tuteja, Ramzi G. Salloum, Amanda L. Elchynski, D. Max Smith, Elizabeth Rowe, Kathryn V. Blake, Nita A. Limdi, Christina L. Aquilante, Jill Bates, Amber L. Beitelshees, Amber Cipriani, Benjamin Q. Duong, Philip E. Empey, Christine M. Formea, J. Kevin Hicks, Pawel Mroz, David Oslin, Amy L. Pasternak, Natasha Petry, Laura B. Ramsey, Allyson Schlichte, Sandra M. Swain, Kristen M. Ward, Kristin Wiisanen, Todd C. Skaar, Sara L. Van Driest, Larisa H. Cavallari, Jeffrey R. Bishop, for the IGNITE Pharmacogenetics Working Group

Connect to this object online.